Currently, understanding the regulatory mechanisms of astrocytic risk factors in AD, such as GFAP [13,19,20], tau [20,21], and ApoE [22,23,24,25], stands as a prominent area of research focus. The gene discussed is MAPT; the disease is Alzheimer disease.